WGS
What one share of GeneDx Holdings holds
Services – Health Services
•“Legacy GeneDx” refer to GeneDx, LLC, a Delaware limited liability company, which we acquired on April 29, 2022 (the “Acquisition”);
GeneDx Holdings’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $15.90 |
|---|---|
| Profit | −$3.72 |
| Capex (buildings and equipment) | $0.95 |
| Free cash flow | −$2.65 |
| Cash and investments | $4.45 |
| Debt | $3.25 |
| Book value | $8.19 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2021 | $1.96 | −$2.27 | $0.09 | −$1.85 | — | — |
| 2022 | $22.93 | −$53.63 | $0.70 | −$31.88 | — | $21.55 |
| 2023 | $8.33 | −$7.23 | $0.22 | −$7.63 | — | $8.78 |
| 2024 | $11.36 | −$1.94 | $0.20 | −$1.26 | — | $8.75 |
| 2025 | $14.93 | −$0.73 | $0.66 | $0.50 | — | $10.54 |